A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis

Filipa Marujo,Simon J. Pelham,João Freixo,Ana Isabel Cordeiro,Catarina Martins,Jean-Laurent Casanova,Wei-Te Lei,Anne Puel,João Farela Neves
DOI: https://doi.org/10.1007/s10875-021-01026-2
IF: 8.542
2021-04-07
Journal of Clinical Immunology
Abstract:Inborn errors of the IL-17-mediated signaling have been associated with chronic mucocutaneous candidiasis (CMC). We describe a patient with CMC, atopic dermatitis, enamel dysplasia, and recurrent parotitis harboring a novel compound heterozygous mutation of <i>TRAF3IP2</i>, leading to autosomal recessive ACT1 deficiency and deficient IL-17 signaling.
immunology
What problem does this paper attempt to address?